Fate Therapeutics Inc (FATE)

Cash & Short-Term Investments

$153.77M

Quarterly · Period ending: · USD

FATE logo

FATE Cash & Short-Term Investments

Latest reported$153.77M
FATE Quarterly Cash & Short-Term Investments ($9.09M → $153.77M)
High-resolution chart · PNG

FATE cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Fate Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
153,770,000
174,822,000
203,657,000
215,423,000
222,830,000
240,425,000
279,068,000
296,923,000
304,879,000
383,544,000
315,175,000
349,734,000
377,935,000
408,898,000
436,227,000
505,136,000
568,850,000
573,772,000
615,910,000
678,701,000
695,596,000
790,135,000
482,916,000
488,805,000
533,409,000
203,284,000
221,427,000
302,823,000
162,008,000
183,033,000
201,007,000
211,192,000
78,019,000
88,634,000
100,949,000
69,214,000
71,013,000
82,300,000
92,112,000
46,619,000
45,930,000
55,612,000
64,809,000
72,857,000
81,176,000
42,349,000
49,101,000
45,530,000
42,012,000
47,881,000
54,036,000
19,082,000
3,399,000
4,647,000
9,087,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.